Jefferies Group LLC Sage Therapeutics, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 9,250 shares of SAGE stock, worth $80,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,250

Previous 9,250 -0.0%

Holding current value

$80,290

Previous $298,000 21.48%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	BUY	$27.52 - $37.99 $130,720 - $180,452	4,750 Added 105.56%	9,250 $298,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $85,477 - $117,996	3,106 Added 50.55%	9,250 $299,000
Q1 2022 Sep 21, 2023	BUY	$30.71 - $45.71 $61,235 - $91,145	1,994 Added 79.57%	4,500 $148,000
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $111,722 - $166,292	3,638 Added 145.17%	6,144 $148,000
Q4 2021 Sep 21, 2023	SELL	$37.06 - $47.11 $55,367 - $70,382	-1,494 Reduced 37.35%	2,506 $106,000

Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $55,367 - $70,382	-1,494 Reduced 37.35%	2,506 $107,000
Q3 2021 Sep 21, 2023	SELL	$40.26 - $57.37 $840,548 - $1.2 Million	-20,878 Reduced 83.92%	4,000 $177,000
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $840,548 - $1.2 Million	-20,878 Reduced 83.92%	4,000 $177,000
Q2 2021 Sep 21, 2023	BUY	$54.88 - $79.29 $322,584 - $466,066	5,878 Added 30.94%	24,878 $1.41 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $322,584 - $466,066	5,878 Added 30.94%	24,878 $1.41 Million
Q1 2021 Sep 21, 2023	BUY	$70.65 - $96.76 $70,650 - $96,760	1,000 Added 5.56%	19,000 $1.42 Million
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $70,650 - $96,760	1,000 Added 5.56%	19,000 $1.42 Million
Q4 2020 Sep 21, 2023	BUY	$58.41 - $89.06 $511,087 - $779,275	8,750 Added 94.59%	18,000 $1.56 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $554,895 - $846,070	-9,500 Reduced 34.55%	18,000 $1.56 Million
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $308,475 - $468,375	-7,500 Reduced 21.43%	27,500 $1.68 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $639,278 - $1.06 Million	24,635 Added 237.67%	35,000 $1.46 Million
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $163,515 - $482,981	-6,253 Reduced 37.63%	10,365 $298,000
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $204,250 - $525,289	3,394 Added 25.67%	16,618 $1.2 Million
Q3 2019 Nov 13, 2019	BUY	$140.29 - $189.96 $462,255 - $625,918	3,295 Added 33.19%	13,224 $1.86 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $1.04 Million - $1.2 Million	-6,571 Reduced 39.82%	9,929 $1.82 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $808,168 - $1.48 Million	9,047 Added 121.39%	16,500 $2.62 Million
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $610,698 - $1.04 Million	7,453 New	7,453 $714,000

Others Institutions Holding SAGE

# of Institutions

Shares Held

6.2M

Call Options Held

37.8K

Put Options Held

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Sage Therapeutics, Inc. Transaction History